Pfizer COVID-19 vaccine wins crucial emergency use approval as US cases soar
Published
After nine hours of non-stop debate, a high powered US vaccine advisory panel endorsed mass use of the Pfizer-BioNTech Covid-19 vaccine, putting the country just one step away from a historic vaccination campaign against a virus that has killed more than 292,000 Americans.
Shots could come within days. The US Food and Drug...